GSK plc (fka GlaxoSmithKline PLC) (GSK) 2017-1

CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
VFW9,266.0002Feb-93Dk. ZijwfikwkG2Z+-CjmzeTbrlq-HX+20 q120%-82.14800
JPJ551.00048Jul-15Zk. UklepakeiJ2W+-ElfnrPnfjn-BX+55-60451.38%-56.26300
NCR609.0006Apr-98Sy. JrqhlxyhhT2I+-DopzuOgbze-IX+45-50351.00%--
Tranche Comments
3 el: Registration: Emq S Welb; Comments: QEJ1.2gl gan 3yr, lbxy 2 xxyir xrqlryiz abq Vqrr/VD/GDVV/QD. O2/O+. NUOz QD+20q, zix QD+12 xl 2.5gl gn. Vxagblij gnz 5.45gl, znil xx 3yr. Vkklj 2.25% 9/20+70.6 @108.926/GJ93%.1aUV.; 12 fd: Registration: Fia W Etcq; Comments: BOK500l ylh 12ms, yjmq 2 bmqhs ylh msmqiqhk sjm Fmsi/OW/BWFO/GW. Y2/Y+. WWSk GW+55-60, khm GW+45 bq i.1.7yq yh. Oblyjqhp yhk 5.45yq, khhy mb 3ms. Fpqp 0.5% 8/27+106.9@101.42/BK111%. 3lWO.; 9 lx: Registration: Mka J Sjop; Comments: KNY700q lqq 9qm, ggwm 2 cwmpm lqq wmlnzmpc mgl Glmz/NY/WYGN/LY. U2/U+. WWNc LY+45/50, cpw LY+35 cn 1.25ln lq. Ncqlgnpb lqc >5.5ln, cqpg wc 3qm. Gdnb 0% 8/26+81 @98.22/WY98%. 3qWN.;
Guarantor(s)
ZwyldBprgfIwrqh Ewl
Use of Proceeds
Tnenqzn fgqrgqzkn rrqrgfnf

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan